Kavallaris M - Search Results

1

Microtubules and resistance to tubulin-binding agents.

Kavallaris M. Kavallaris M. Nat Rev Cancer. 2010 Mar;10(3):194-204. doi: 10.1038/nrc2803. Epub 2010 Feb 11. Nat Rev Cancer. 2010. PMID: 20147901 Review.

2

Reduced drug accumulation as the mechanism of extreme clinical resistance to methotrexate in the human T-cell leukemia xenograft, LALW-2.

Norris MD, Haber M, Kavallaris M, Brian MJ, Lutze LH, White L, Stewart BW. Norris MD, et al. Among authors: kavallaris m. Cancer. 1991 Sep 1;68(5):981-7. doi: 10.1002/1097-0142(19910901)68:5<981::aid-cncr2820680512>3.0.co;2-w. Cancer. 1991. PMID: 1913492

3

Phenotypic and cytogenetic analysis of atypical multidrug resistance in human leukaemic cells selected with methotrexate at high concentration.

Kavallaris M, Haber M, Norris MD, Pittman SM, Reed C, Stewart BW. Kavallaris M, et al. Cancer Lett. 1990 Jun 15;51(3):193-201. doi: 10.1016/0304-3835(90)90102-4. Cancer Lett. 1990. PMID: 1972035

4

Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein.

Haber M, Norris MD, Kavallaris M, Bell DR, Davey RA, White L, Stewart BW. Haber M, et al. Among authors: kavallaris m. Cancer Res. 1989 Oct 1;49(19):5281-7. Cancer Res. 1989. PMID: 2569932

5

Resistance to drugs associated with the multidrug resistance phenotype following selection with high-concentration methotrexate.

Haber M, Reed C, Kavallaris M, Norris MD, Stewart BW. Haber M, et al. Among authors: kavallaris m. J Natl Cancer Inst. 1989 Aug 16;81(16):1250-4. doi: 10.1093/jnci/81.16.1250. J Natl Cancer Inst. 1989. PMID: 2754745

6

An assay for the determination of reduced methotrexate accumulation in cells displaying limited viability in vitro.

Haber M, Norris MD, Kavallaris M, Camacho M, Madafiglio J, Baker CJ, White L, Stewart BW. Haber M, et al. Among authors: kavallaris m. Cancer Lett. 1995 Oct 20;97(1):49-55. doi: 10.1016/0304-3835(95)03950-2. Cancer Lett. 1995. PMID: 7585477

7

Resistance to tetracycline, a hydrophilic antibiotic, is mediated by P-glycoprotein in human multidrug-resistant cells.

Kavallaris M, Madafiglio J, Norris MD, Haber M. Kavallaris M, et al. Biochem Biophys Res Commun. 1993 Jan 15;190(1):79-85. doi: 10.1006/bbrc.1993.1013. Biochem Biophys Res Commun. 1993. PMID: 8093660

8

Involvement of MDR1 P-glycoprotein in multifactorial resistance to methotrexate.

Norris MD, De Graaf D, Haber M, Kavallaris M, Madafiglio J, Gilbert J, Kwan E, Stewart BW, Mechetner EB, Gudkov AV, Roninson IB. Norris MD, et al. Among authors: kavallaris m. Int J Cancer. 1996 Mar 1;65(5):613-9. doi: 10.1002/(SICI)1097-0215(19960301)65:5<613::AID-IJC10>3.0.CO;2-8. Int J Cancer. 1996. PMID: 8598312 Free article.

9

MDR1 and multidrug resistance-associated protein (MRP) gene expression in epithelial ovarian tumors.

Kavallaris M, Leary JA, Barrett JA, Friedlander ML. Kavallaris M, et al. Cancer Lett. 1996 Apr 19;102(1-2):7-16. doi: 10.1016/0304-3835(96)04143-2. Cancer Lett. 1996. PMID: 8603381

10

The role of multidrug resistance-associated protein (MRP) expression in multidrug resistance.

Kavallaris M. Kavallaris M. Anticancer Drugs. 1997 Jan;8(1):17-25. doi: 10.1097/00001813-199701000-00002. Anticancer Drugs. 1997. PMID: 9147606 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results